Based on the Ideaya Biosciences Inc stock forecast from 6 analysts, the average analyst target price for Ideaya Biosciences Inc is USD 57.40 over the next 12 months. Ideaya Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ideaya Biosciences Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Ideaya Biosciences Inc’s stock price was USD 19.75. Ideaya Biosciences Inc’s stock price has changed by +8.64% over the past week, +15.84% over the past month and -51.41% over the last year.
No recent analyst target price found for Ideaya Biosciences Inc
No recent average analyst rating found for Ideaya Biosciences Inc
Company Overview Ideaya Biosciences Inc
IDEAYA Biosciences, Inc., a precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung (SCLC) and MTAP-deletion urothelial cancer; IDE849, a DLL3 antibody drug conjugate inhibitor that is in Phase 1 clinical trial for the treatment of SCLC and neuroendocrine tumors; IDE275, a Werner Helicase inhibitor that is in Phase 1 clinical trial for patients having tumors with high microsatellite instability; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1/2 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; IDE705 (GSK101), a Poly Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other mutations associated with HRD. It also develops preclinical programs, including IDE892, a MTA-cooperative PRMT5 inhibitor; IDE034, a B7H3/PTK7 topo-I-payload bispecific BsADC; and IDE251, a KAT6/7 inhibitor. In addition, the company offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Gilead Sciences, Inc., Merck, Biocytogen, Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Read Less
IDEAYA Biosciences, Inc., a precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that...Read More
Frequently Asked Questions About Ideaya Biosciences Inc (IDYA) Stock
Based on ratings from 6 analysts Ideaya Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 14 buy, 1 sell and hold ratings.
Unfortunately we do not have enough data on IDYA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for IDYA is USD 57.40 over the next 12 months. The maximum analyst target price is USD 65 while the minimum anlayst target price is USD 50.
Unfortunately we do not have enough data on IDYA's stock to indicate if its overvalued.
The last closing price of IDYA's stock was USD 19.75.
The most recent market capitalization for IDYA is USD 1.47B.
Based on targets from 6 analysts, the average taret price for IDYA is projected at USD 57.40 over the next 12 months.
This means that IDYA's stock price may go up by +190.63% over the next 12 months.
We can't find any ETFs which contains Ideaya Biosciences Inc's stock.
As per our most recent records Ideaya Biosciences Inc has 131 Employees.
Ideaya Biosciences Inc's registered address is 5000 Shoreline Court, South San Francisco, CA, United States, 94080.
You can get more information about it from Ideaya Biosciences Inc's website at https://www.ideayabio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Ideaya Biosciences Inc (IDYA) Stock
Based on ratings from 6 analysts Ideaya Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 14 buy, 1 sell and hold ratings.
Unfortunately we do not have enough data on IDYA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for IDYA is USD 57.40 over the next 12 months. The maximum analyst target price is USD 65 while the minimum anlayst target price is USD 50.
Unfortunately we do not have enough data on IDYA's stock to indicate if its overvalued.
The last closing price of IDYA's stock was USD 19.75.
The most recent market capitalization for IDYA is USD 1.47B.
Based on targets from 6 analysts, the average taret price for IDYA is projected at USD 57.40 over the next 12 months.
This means that IDYA's stock price may go up by +190.63% over the next 12 months.
We can't find any ETFs which contains Ideaya Biosciences Inc's stock.
As per our most recent records Ideaya Biosciences Inc has 131 Employees.
Ideaya Biosciences Inc's registered address is 5000 Shoreline Court, South San Francisco, CA, United States, 94080.
You can get more information about it from Ideaya Biosciences Inc's website at https://www.ideayabio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IDYA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
